GNLXMICRO

Genelux Corporation

HealthcareBiotechnology
$2.90
$0.00(+1.05%)
52W$2.29
$8.54
Updated Jun 30, 02:00 AM
RSI47
RS Rating34/99
Beta2.38
Volatility85%
F-Score3/9
Mkt Cap$109M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Genelux Corporation is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 34), showing significant lag compared to the market leaders. Earnings contraction of 5% provides fundamental context to the price action. Investors should exercise caution due to high volatility (85% annualized), which requires wider risk management.

Relative Strength
34
out of 99
Lagging
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
2.38
vs S&P 500
HIGH BETA
52W Position
10%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$2.87
50 SMA > 100 SMA$2.74
100 SMA > 150 SMA$3.11
150 SMA > 200 SMA$3.71

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$2.94-1.30%BELOW
50 SMA$2.87+1.11%ABOVE
100 SMA$2.74+5.70%ABOVE
150 SMA$3.11-6.82%BELOW
200 SMA$3.71-21.82%BELOW

Price Performance

1D+1.0%
1W-0.7%
1M-4.9%
3M+26.1%
6M-33.8%
YTD-36.3%
1Y+1.0%
3Y-54.5%
52-Week Trading Range10% from low
$2.90
52W Low$2.29
52W High$8.54

Technical Indicators

RSI (14)NEUTRAL
47.3
305070
Setup ScoreCOOL
4/10
Base depth: 32.6%

Risk Profile

Beta
2.38
52W Vol
85%
ATR
$0.17
Max DD (1Y)
-72%

Volume Analysis

Today
33.2K
50D Avg
155.2K
Vol Ratio
0.21x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25+9%
$-0.20
Q3'25-11%
$-0.21
Q4'25+7%
$-0.25
Q1'26-5%
$-0.22
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:-91.03%
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+1.12%

Stock Price CAGR

10 Years:-7.24%
5 Years:-13.96%
3 Years:-54.50%
1 Year:+1.05%

Return on Equity

10Y Avg:-148.6%
5Y Avg:-148.6%
3Y Avg:-148.6%
Last Year:-165.2%

Key Metrics

Market Cap$109M
Gross Margin-70.8%
Net Margin-4018.1%
Piotroski F-Score3/9

Frequently Asked Questions

Is GNLX in an uptrend right now?

GNLX has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is GNLX overbought or oversold?

GNLX's RSI (14) is 47. The stock is in neutral territory, neither overbought nor oversold.

Is GNLX outperforming the market?

GNLX has a Relative Strength (RS) Rating of 34 out of 99. GNLX is currently lagging the broader market.

Where is GNLX in its 52-week range?

GNLX is trading at $2.90, which is 34% of its 52-week high ($8.54) and 10% above its 52-week low ($2.29).

How volatile is GNLX?

GNLX has a Beta of 2.38 and 52-week volatility of 85%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.